Biomarker Assay Development

San Diego, CA (January 26-28, 2008)

The main conference held by the Cambridge Healthtech Institute will be focused on seven main themes: Incorporating Assay Development into Overall Biomarker Strategy, Multiplex Biomarker Assays, Total vs. Free Analyte Quantification, Biomarker Assay Development for Diagnostics, Translation from In-House Development to Clinical Laboratory, Circulating Cell Biomarker Assays and Assay Development for Protein Biomarkers.

Coverage Includes:

* Incorporating assay development into an overall biomarker strategy   * Multiplexed biomarker assays   * Fit-for-purpose assay development   * Total vs. free analyte quantification   * In-house assay development vs. off-the-shelf solutions vs. outsourcing   * Translation from in-house development to clinical laboratory   * Assay development for genomic and proteomic biomarkers   * Circulating cell assays   * Novel detection technologies

Pre-Conference Events:

* Tutorial: Fit-for-Purpose Biomarker Assay Development and Validation   * Workshop: Novel Cancer Biomarkers

More: http://www.healthtech.com/bma/overview.aspx